Up next at #DAVALung: Perioperative Therapy. Moderator Jay Lee leads a multidisciplinary panel on how neoadjuvant and adjuvant approaches are reshaping care, from patient selection to coordinating systemic therapy, radiation, and surgery.
This afternoon at #DAVALung: sessions on synergistic agents with checkpoint inhibitors, perioperative therapy advances, and genomic/proteomic/metabolomic insights in thoracic malignancies. Join us in person or virtually:
🔗 https://t.co/ueZuybPYG1
Coming up Next: Synergistic Agents with Checkpoint Inhibitors. Join moderator Valsamo Anagnostou and an expert faculty panel as they explore promising combination strategies designed to enhance immunotherapy outcomes. #DAVALung.
ctDNA MRD may reshape resectable NSCLC care. @ValsamoA@HopkinsMedicine reviews 77T, where 87% of nivolumab-arm patients had baseline ctDNA and clearance may guide escalation/de-escalation. She emphasized on clinical sensitivity of ctDNA sensitivity. #DAVALung
Beyond one-size-fits-all salvage therapy: @ValsamoA from @HopkinsMedicine, discussed how multi-omic profiling of IO-resistant NSCLC could inform biomarker-driven and combination treatment approaches. #DAVALung
Starting soon: Checkpoint Inhibitors in NSCLC/HNSCC, moderated by @PatelOncology from @UCSDHealth. Join us for an expert discussion on the evolving role of checkpoint inhibitors across lung and head & neck cancers.#DAVALung
Διεθνής διάκριση για Ελληνίδα ογκολόγο: Η Έλσα Αναγνώστου βραβεύτηκε στις ΗΠΑ για το έργο της στον καρκίνο | https://t.co/bku5FffDo3 https://t.co/Y3FoJO75C3
Διεθνής διάκριση για Ελληνίδα ογκολόγο: Η Έλσα Αναγνώστου βραβεύτηκε στις ΗΠΑ για το έργο της στον καρκίνο | https://t.co/bku5FffDo3 https://t.co/Y3FoJO75C3
📌Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
OncoDaily’s 2024 list of the Top 100 Xfluencers in Lung Cancer recognizes key leaders in the field, offering invaluable insights into the latest research and advocacy efforts.
https://t.co/RfZRshJsy3
It was great to learn from #liquidbiopsy experts in the EACR Liquid Biopsies conference @EACRnews ! Proud to have @ValsamoA on board in our TransAtlantic Cancer Alliance project 👏🏽
Another phenomenal @sitcancer meeting, pleased to present our work on ctDNA molecular response as an early predictor of immunotherapy response that led to the first ctDNA-adaptive clinical trial for patients with #lungcancer! @HopkinsMedicine@HopkinsThoracic#sitc2024
Honoured to be inducted in the Interurban Clinical Club founded in 1905 by Dr. William Osler! Our 227th symposium at @MGHMedicine@harvardmed covered from #groundbreaking research to freedom of speech & history of #medicine!Thanks @bmprii for being a superb host! @HopkinsMedicine